Early and progressive accumulation of reactive microglia in the Huntington disease brain

Journal of Neuropathology and Experimental Neurology

Volumn 60, Issue 2, 2001, Pages 161-172

  Sapp, E ^a   Kegel, K B ^a   Aronin, N ^b   Hashikawa, T ^c   Uchiyama, Y ^d   Tohyama, K ^e   Bhide, P G ^a   Vonsattel, J P ^a   Difiglia, Marian ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^d OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^e IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Human brain; Huntingtin; Huntington disease; Mutant huntingtin; Nuclear inclusions; Reactive microglia; Thymosin 4

Indexed keywords

HUNTINGTIN; THYMOSIN BETA4;

ARTICLE; BRAIN CORTEX; CELL ACTIVATION; CELL DEATH; CONTROLLED STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; GLOBUS PALLIDUS; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MICROGLIA; NEOSTRIATUM; NEUROPIL; PATHOGENESIS; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; WHITE MATTER;

EID: 0035111235     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/60.2.161     Document Type: Article

References (62)

1. Huntington disease
2. Neuropathological classification of Huntington's disease
3. Morphometric analysis of the prefrontal cortex in Huntington's disease
4. Neuronal and glial somal size in the prefrontal cortex: A postmortem morphometric study of schizophrenia and Huntington disease
5. Decreased neuronal and increased oligodendroglial densities in Huntington's disease caudate nucleus
6. Microglia: A sensor for pathological events in the CNS
7. The CNS acute inflammatory response to excitotoxic neuronal cell death
8. Neuroglia
9. Microglia
10. Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor
11. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
12. Microglia reaction in Pick's disease
13. Reactive microglia in Creutzfeldt-Jakob disease
14. Evidence of active nerve cell degeneration in the substantia nigra of human years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
15. Complement activation by β-amyloid in Alzheimer disease
16. Inflammatory mechanisms and anti-inflammatory therapy in Alzheimer's disease
17. Importance of immunological and inflammatory processes in the pathogenesis and therapy of Alzheimer's disease
18. Aspartate residue 7 in amyloid β-protein is critical for classical complement pathway activation: Implications for Alzheimer's disease pathogenesis
19. Complement interactions with amyloid-β1-42: A nidus for inflammation in AD brains
20. Fibrillar β-amyloid induces microglia phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo
21. Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of β-amyloid and prion proteins
22. Early detection of quinolinic acid immunoreactivity (ir) in microglia/macrophages after intracerebral infusion of 3-hydroxyanthranilic acid in rats
23. Thymosin β4 and Fx, an actinsequestering peptide, are indistinguishable
24. Thymosin β4 (Fx peptide) is a potent regulator of actin polymerization in living cells
25. Three dimensional morphology of residential and reactive microglia immunostained by anti-β-thymosin antibody
26. CR3/43, a marker for activated human microglia: Application to diagnostic neuropathology
27. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain
28. Huntingtin localization in brains of normal and Huntington's disease patients
29. Localization of thymosin β4 to the neural tissues during the development of Xenopus laevis, as studied by in situ hybridization and immunohistochemistry
30. Differential expression of the human thymosin beta-4 gene in lymphocytes, macrophages, and granulocytes
31. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons
32. Thymosin β4 binds actin in an extended conformation and contacts both the barbed and pointed ends
33. Thymosin β4 sequesters the majority of G-actin in resting human polymorpho-nuclear leukocytes
34. Increase in HLA-DR immunoreactive microglia in frontal and temporal cortex of chronic schizophrenics
35. Axonal transport of N-terminal huntingtin suggests early pathology of corticostriatal projections in Huntington disease
36. A comparison of astrocytic structure in cerebral cortex and striatum in Huntington Disease
37. The cortical neuritic pathology of Huntington's disease
38. Differential loss of striatal projection neurons in Huntington disease
39. Evidence for a preferential loss of enkephalin immunoreactivity in the external globus pallidus in low grade Huntington's disease using high resolution image analysis
40. Pathologic changes in Huntington's chorea
41. Morphometric demonstration of atrophic change in the cerebral cortex
42. Differential macrophage responses in the peripheral and central nervous system during wallerian degeneration of axons
43. Microglia and astrocytic cell responses in the rat hippocampus after an intracerebroventricular kainic acid injection
44. Lesion of the rat entorhinal cortex leads to a rapid microglial reaction in the dentate gyrus. A light and electron microscopical study
45. Beitrage zur kenntnis der pathologischen neuroglia und ihrer beziehungen zu den abbau vorgangen im nervengewebe
46. Change of phosphotyrosine immunoreactivity on microglia in the rat substantia nigra following striatal ischemic injury
47. Extensive and long-lasting changes of glial cells following transection of the postcommissural fornix in the adult rat
48. Neuronal control of the immune response in the central nervous system: Linking brain immunity to neurodegeneration
49. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation
50. Huntingtin interacts with a family of WW domain proteins
51. Proteasome inhibitors: Valuable new tools for cell biologists
52. Generation of neuronal intranuclear inclusions by polyglutamine-GFP: Analysis of inclusion clearance and toxicity as a function of polyglutamine length
53. Microglial activation resulting from CDC40-CD40L interaction after β-amyloid stimulation
54. Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease
55. Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease: A quantitative Golgi study
56. Developmental expression of mRNAs encoding thymosins β4 and β10 in rat brain and other tissues
57. Expression of thymosin β4 gene during xenopus laevis embryogenesis
58. Identification and characterization of mRNAs regulated by nerve growth factor in PC12 cells
59. Expression of thymosin beta4 messenger RNA in normal and kainate-treated rat forebrain
60. Mapping the binding site of thymosin β4 on actin by competition with G-actin binding proteins indicates negative co-operativity between binding sites located on opposite subdomains of actin
61. Risk of Alzheimer's disease and duration of NSAID use
62. Nonsteroidal anti-inflammatory drug use and Alzheimer type pathology in aging